Trend-Following Backtester · Guide · backtest 한국어

equity · CN

Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A backtest

10 trend-following strategies were compared on the full daily history of Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A. 4 beat buy-and-hold CAGR; Supertrend ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is Keltner 채널 돌파 (CAGR 7.1%, MDD -24.6%).

Data 2020-01-23 ~ 2026-07-31daily bars 1,579 (6.5 years)Costs 0.5%Venue SSEMonthly snapshot 2026-07-31

Results by strategy

4 of 10 beat buy and hold (CAGR 7.8%, drawdown -80.2%).

Sharpe leader (same as main): Supertrend — CAGR 19.8%, MDD -54.7%, Sharpe 0.67, 51% exposure.

Return/drawdown alternative: Keltner 채널 돌파 — CAGR is 12.0%p higher than buy and hold, while drawdown improves by 25.5%p (CAGR 7.1%, MDD -24.6%, exposure 12%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
Supertrend
period=36, mult=4.9
19.8%-54.7%0.670.363.2x1551%
SMA 크로스오버
fast=49, slow=108
16.2%-50.6%0.580.322.7x1153%
Donchian 채널 돌파
entryN=29, exitN=30
11.4%-52.1%0.480.222.0x2149%
Keltner 채널 돌파
emaPeriod=26, atrPeriod=12, mult=2.9
7.1%-24.6%0.420.291.6x1212%
ROC 모멘텀
n=97, threshold=-0.01
8.2%-49.2%0.400.171.7x7358%
EMA 크로스오버
fast=58, slow=66
7.7%-56.4%0.390.141.6x1353%
볼린저 밴드 돌파
n=38, k=2.1
6.6%-43.1%0.370.151.5x3029%
MACD
fast=19, slow=40, signal=15
6.1%-49.7%0.350.121.5x7449%
ADX / DI 방향성
period=23, threshold=33
2.8%-19.4%0.250.141.2x75%
Parabolic SAR
step=0.03, maxStep=0.06
1.2%-58.0%0.220.021.1x10249%
Buy and hold7.8%-80.2%0.410.101.6x1100%
1x 2021 2022 2023 2024 2025 2026 SupertrendBuy and hold
Supertrend: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -20% -40% -60% -80% 2021 2022 2023 2024 2025 2026 Buy and holdSupertrend
Supertrend maximum drawdown -54.7% (2020-08-05 → 2022-09-01), recovered after 1,678 days.

Rules of the top strategy

Trades the direction of a volatility-based trend line that trails below/above price.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupAll asset reports

Read next